Experimental Respiratory Infection of Marmosets (Callithrix jacchus) with Ebola Virus Kikwit

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S336-S345

  Smither, Sophie J ^a   Nelson, Michelle ^a   Eastaugh, Lin ^a   Nunez, Alejandro ^b   Salguero, Francisco J ^c   Lever, Mark S ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

aerosol; animal model; Ebola virus; Ebola virus disease; filovirus; human disease correlates; marmoset; nonhuman primate; pathology

Indexed keywords

CASPASE 3; EBOLA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING TIME; CALLITHRIX JACCHUS; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EDEMA; FEVER; GRANULOCYTE; HYPERTRANSAMINASEMIA; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; LETHALITY; MACROPHAGE; MONOCYTE; NONHUMAN; PERIVASCULAR EDEMA; PRIORITY JOURNAL; THROMBOCYTE COUNT; VIRAL RESPIRATORY TRACT INFECTION; VIRUS HEPATITIS; VIRUS LOAD; VIRUS PATHOGENESIS; ANIMAL; CALLITHRIX; DISEASE MODEL; EBOLAVIRUS; FEMALE; IMMUNOLOGY; LIVER; LUNG; MALE; MONKEY DISEASE; PATHOGENICITY; PATHOLOGY; RESPIRATORY TRACT INFECTION; SPLEEN; VIROLOGY;

ANIMALS; CALLITHRIX; DISEASE MODELS, ANIMAL; EBOLA VACCINES; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; LIVER; LUNG; MALE; MONKEY DISEASES; RESPIRATORY TRACT INFECTIONS; SPLEEN; VIRAL LOAD;

EID: 84941977477     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv371     Document Type: Article

References (50)

1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-62.
2. Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM. Ebola and Marburg haemorrhagic fever. J Clin Virol 2015; 64:111-9.
3. Hartman AL, Towner JS, Nichol ST. Ebola and Marburg hemorrhagic fever . Clin Lab Med 2010; 30:161-77.
4. Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, Peters CJ. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol 1996; 11: 115-34.
5. Bray M. Defense against filoviruses used as biological weapons. Antiviral Res 2003; 57:53-60.
6. OsterholmMT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: what we know and what we do not know. MBio 2015; 6:e00137-15.
7. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002; 287:2391-405.
8. Friedrich BM, Trefry JC, Biggins JE, et al. Potential vaccines and postexposure treatments for filovirus infections. Viruses 2012; 4:1619-50.
9. Marzi A, Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines 2014; 13:521-31.
10. Wong G, Qiu X, Olinger GG, Kobinger GP. Post-exposure therapy of filovirus infections. Trends Microbiol 2014; 22:456-63.
11. Leffel EK, Reed DS. Marburg and Ebola viruses as aerosol threats. Biosec Bioterror 2004; 2:186-90.
12. Reed DS, LackemeyerMG, Garza NL, Sullivan LJ, Nichols DK. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: difference in disease course and clinical pathology. Microbes Infect 2011; 13:930-6.
13. Bente D, Gren J, Strong JE, Feldmann H. Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2009; 2:12-7.
14. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
15. Gibb TR, Bray M, Geisbert TW, et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 2001; 125:233-42.
16. Bray M. The role of the type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001; 82:1365-73.
17. Lever MS, Piercy TJ, Steward JA, et al. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptordeficient mice. J Med Microbiol 2012; 61:8-15.
18. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996; 120: 140-55.
19. Schou S, Hansen AK. Marburg and Ebola virus infections in laboratory non-human primates: A literature review. Comp Med 2000; 50:108-23.
20. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70.
21. Shurtleff AC, Warren TK, Bavari S. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opin Drug Discov 2011; 6:233-50.
22. Qiu X, Audet J, Wong G, et al. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 2012; 4:138ra81.
23. Pettitt J, Zeitlin L, Kim do H, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med 2013; 5:199ra113.
24. Choi JH, Jonsson-Schmunk K, Qiu X, et al. A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infection. Mol Pharm 2014; doi:10.1021/mp500646d.
25. Orsi A, Rees D, Andreini I, Venturella S, Cinelli S, Oberto G. Overview of the marmoset as a model in nonclinical development of pharmaceutical products. Regul Toxicol Pharmacol 2011; 59:19-27.
26. Lever MS, Stagg AJ, Nelson M, et al. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2008; 89:171-9.
27. Nelson M, Lever MS, Savage VL, et al. Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2009; 90:109-18.
28. Nelson M, Salguero FJ, Dean RE, et al. Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2014; 95:378-91.
29. Carrion R Jr, Brasky K, Mansfield K, et al. Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol 2007; 81:6482-90.
30. Adams AP, Aronson JF, Tardif SD, et al. Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol 2008; 82:9035-42.
31. Carrion R Jr, Ro Y, Hoosien K, et al. A small nonhuman primate model for filovirus-induced disease. Virology 2011; 420:117-24.
32. Smither SJ, Nelson M, Eastaugh L, et al. Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2013; 94:156-68.
33. Willyard C. Advances in marmoset and mouse models buoy Ebola research. Nat Med 2014; 20:1356-7.
34. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 1996; 93:3602-7.
35. Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 2011; 204:S941-6.
36. Kugelman JR, Lee MS, Rossi CA, et al. Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection. PLoS One 2012; 7:e50316.
37. Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG Jr. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J Virol Methods 2013; 193:565-71.
38. Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995; 76:227-36.
39. Twenhafel NA, Mattix ME, Johnson JC, et al. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques. Vet Pathol 2013; 50:514-29.
40. Wahl-Jensen V, Bollinger L, Safronetz D, de Kok-Mercado F, Scott DP, Ebihara H. Use of the Syrian hamster as a new model of Ebola virus disease and other viral hemorrhagic fevers. Viruses 2012; 4:3754-84.
41. Nakayama E, Saijo M. Animal models for Ebola and Marburg virus infections. Front Microbiol 2013; 4:267.
42. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011; 204:S810-6.
43. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015; 372:40-7.
44. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371:2092-100.
45. Davis KJ, Anderson AO, Geisbert TW, et al. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997; 121:805-19.
46. Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DI, Neild GH, Barrett AJ. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 1983; 2:1055-8.
47. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001; 125:243-53.
48. Bray M, Geisbert TW. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005; 37:1560-6.
49. Bradfute SB, Swanson PE, Smith MA, et al. Mechanisms and consequences of Ebolavirus-induced lymphocyte apoptosis. J Immunol 2010; 184:327-35.
50. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-86.